230 related articles for article (PubMed ID: 29860836)
1. Silencing of Intestinal Glycoprotein CD98 by Orally Targeted Nanoparticles Enhances Chemosensitization of Colon Cancer.
Xiao B; Viennois E; Chen Q; Wang L; Han MK; Zhang Y; Zhang Z; Kang Y; Wan Y; Merlin D
ACS Nano; 2018 Jun; 12(6):5253-5265. PubMed ID: 29860836
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticles with surface antibody against CD98 and carrying CD98 small interfering RNA reduce colitis in mice.
Xiao B; Laroui H; Viennois E; Ayyadurai S; Charania MA; Zhang Y; Zhang Z; Baker MT; Zhang B; Gewirtz AT; Merlin D
Gastroenterology; 2014 May; 146(5):1289-300.e1-19. PubMed ID: 24503126
[TBL] [Abstract][Full Text] [Related]
3. Chondroitin sulfate-functionalized polymeric nanoparticles for colon cancer-targeted chemotherapy.
Zu M; Ma L; Zhang X; Xie D; Kang Y; Xiao B
Colloids Surf B Biointerfaces; 2019 May; 177():399-406. PubMed ID: 30785037
[TBL] [Abstract][Full Text] [Related]
4. Combination Therapy for Ulcerative Colitis: Orally Targeted Nanoparticles Prevent Mucosal Damage and Relieve Inflammation.
Xiao B; Zhang Z; Viennois E; Kang Y; Zhang M; Han MK; Chen J; Merlin D
Theranostics; 2016; 6(12):2250-2266. PubMed ID: 27924161
[TBL] [Abstract][Full Text] [Related]
5. Targeting intestinal inflammation with CD98 siRNA/PEI-loaded nanoparticles.
Laroui H; Geem D; Xiao B; Viennois E; Rakhya P; Denning T; Merlin D
Mol Ther; 2014 Jan; 22(1):69-80. PubMed ID: 24025751
[TBL] [Abstract][Full Text] [Related]
6. Targeted rod-shaped mesoporous silica nanoparticles for the co-delivery of camptothecin and survivin shRNA in to colon adenocarcinoma in vitro and in vivo.
Babaei M; Abnous K; Taghdisi SM; Taghavi S; Sh Saljooghi A; Ramezani M; Alibolandi M
Eur J Pharm Biopharm; 2020 Nov; 156():84-96. PubMed ID: 32882423
[TBL] [Abstract][Full Text] [Related]
7. Glycoprotein CD98 as a receptor for colitis-targeted delivery of nanoparticle.
Xiao B; Yang Y; Viennois E; Zhang Y; Ayyadurai S; Baker M; Laroui H; Merlin D
J Mater Chem B; 2014 Mar; 2(11):1499-1508. PubMed ID: 24729869
[TBL] [Abstract][Full Text] [Related]
8. Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon.
Wu P; Zhou Q; Zhu H; Zhuang Y; Bao J
BMC Cancer; 2020 Apr; 20(1):354. PubMed ID: 32345258
[TBL] [Abstract][Full Text] [Related]
9. Urocanic acid-modified chitosan nanoparticles can confer anti-inflammatory effect by delivering CD98 siRNA to macrophages.
Xiao B; Ma P; Viennois E; Merlin D
Colloids Surf B Biointerfaces; 2016 Jul; 143():186-193. PubMed ID: 27011348
[TBL] [Abstract][Full Text] [Related]
10. Hyaluronic acid-functionalized polymeric nanoparticles for colon cancer-targeted combination chemotherapy.
Xiao B; Han MK; Viennois E; Wang L; Zhang M; Si X; Merlin D
Nanoscale; 2015 Nov; 7(42):17745-55. PubMed ID: 26455329
[TBL] [Abstract][Full Text] [Related]
11. Fab'-bearing siRNA TNFα-loaded nanoparticles targeted to colonic macrophages offer an effective therapy for experimental colitis.
Laroui H; Viennois E; Xiao B; Canup BS; Geem D; Denning TL; Merlin D
J Control Release; 2014 Jul; 186():41-53. PubMed ID: 24810114
[TBL] [Abstract][Full Text] [Related]
12. CD98 siRNA-loaded nanoparticles decrease hepatic steatosis in mice.
Canup BS; Song H; Le Ngo V; Meng X; Denning TL; Garg P; Laroui H
Dig Liver Dis; 2017 Feb; 49(2):188-196. PubMed ID: 27939923
[TBL] [Abstract][Full Text] [Related]
13. A silica-based antioxidant nanoparticle for oral delivery of Camptothecin which reduces intestinal side effects while improving drug efficacy for colon cancer treatment.
Nguyen-Trinh QN; Trinh KXT; Trinh NT; Vo VT; Li N; Nagasaki Y; Vong LB
Acta Biomater; 2022 Apr; 143():459-470. PubMed ID: 35235866
[TBL] [Abstract][Full Text] [Related]
14. Preparation of camptothecin-loaded targeting nanoparticles and their antitumor effects on hepatocellular carcinoma cell line H22.
Yang A; Liu Z; Yan B; Zhou M; Xiong X
Drug Deliv; 2016 Jun; 23(5):1699-706. PubMed ID: 25148540
[TBL] [Abstract][Full Text] [Related]
15. Targeted Treatment of Colon Cancer with Aptamer-Guided Albumin Nanoparticles Loaded with Docetaxel.
Yu Z; Li X; Duan J; Yang XD
Int J Nanomedicine; 2020; 15():6737-6748. PubMed ID: 32982230
[TBL] [Abstract][Full Text] [Related]
16. Polymeric Nanomedicine for Combined Gene/Chemotherapy Elicits Enhanced Tumor Suppression.
Xu B; Xia S; Wang F; Jin Q; Yu T; He L; Chen Y; Liu Y; Li S; Tan X; Ren K; Yao S; Zeng J; Song X
Mol Pharm; 2016 Feb; 13(2):663-76. PubMed ID: 26695934
[TBL] [Abstract][Full Text] [Related]
17. Cyclodextrin nanoparticle bound oral camptothecin for colorectal cancer: Formulation development and optimization.
Ünal S; Aktaş Y; Benito JM; Bilensoy E
Int J Pharm; 2020 Jun; 584():119468. PubMed ID: 32470483
[TBL] [Abstract][Full Text] [Related]
18. In vitro evaluation of paclitaxel loaded amorphous chitin nanoparticles for colon cancer drug delivery.
Smitha KT; Anitha A; Furuike T; Tamura H; Nair SV; Jayakumar R
Colloids Surf B Biointerfaces; 2013 Apr; 104():245-53. PubMed ID: 23337120
[TBL] [Abstract][Full Text] [Related]
19. iRGD-functionalized PEGylated nanoparticles for enhanced colon tumor accumulation and targeted drug delivery.
Ma L; Chen Q; Ma P; Han MK; Xu Z; Kang Y; Xiao B; Merlin D
Nanomedicine (Lond); 2017 Aug; 12(16):1991-2006. PubMed ID: 28745123
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic efficacy and gastrointestinal biodistribution of polycationic nanoparticles for oral camptothecin delivery in early and late-stage colorectal tumor-bearing animal model.
Ünal S; Can Öztürk S; Bilgiç E; Yanık H; Korkusuz P; Aktaş Y; Benito JM; Esendağlı G; Bilensoy E
Eur J Pharm Biopharm; 2021 Dec; 169():168-177. PubMed ID: 34700001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
